|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Douaiher J, Ravipati A, Grams B, Chowdhury
S, Alatise O and Are C: Colorectal cancer-global burden, trends,
and geographical variations. J Surg Oncol. 115:619–630. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Favoriti P, Carbone G, Greco M, Pirozzi F,
Pirozzi RE and Corcione F: Worldwide burden of colorectal cancer: A
review. Updates Surg. 68:7–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zheng R, Zeng H, Zhang S, Chen T and Chen
W: National estimates of cancer prevalence in China, 2011. Cancer
Lett. 370:33–38. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Karanikas M and Esebidis A: Increasing
incidence of colon cancer in patients <50 years old: A new
entity? Ann Transl Med. 4:1642016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang X, Shao S, Gao Y, Zhang M and Lu Y:
Meta-analysis of relationship between extranodal tumor deposits and
prognosis in patients with colorectal cancer. Zhonghua Wei Chang
Wai Ke Za Zhi. 19:334–338. 2016.(In Chinese). PubMed/NCBI
|
|
8
|
Brenner H, Kloor M and Pox CP: Colorectal
cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yusup A, Wang HJ, Rahmutula A, Sayim P,
Zhao ZL and Zhang GQ: Clinical features and prognosis in colorectal
cancer patients with different ethnicities in Northwest China.
World J Gastroenterol. 41:7183–7188. 2013. View Article : Google Scholar
|
|
10
|
Ren Q and Jin B: The clinical value and
biological function of PTTG1 in colorectal cancer. Biomed
Pharmacother. 89:108–115. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gil J, Ramsey D, Szmida E, Leszczynski P,
Pawlowski P, Bebenek M and Sasiadek MM: TheBAXgene as a candidate
for negative autophagy-related genes regulator on mRNA levels in
colorectal cancer. Med Oncol. 34:162017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mansour MA and Senga T: HOXD8 exerts a
tumor-suppressing role in colorectal cancer as an apoptotic
inducer. Int J Biochem Cell Biol. 88:1–13. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Roelofs HM, Te Morsche RH, van Heumen BW,
Nagengast FM and Peters WH: Over-expression of COX-2 mRNA in
colorectal cancer. BMC Gastroenterology. 14:12014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang JS, Yang LQ, Du BR and Gao H: Higher
RABEX-5 mRNA predicts unfavourable survival in patients with
colorectal cancer. Eur Rev Med Pharmacol Sci. 21:2372–2376.
2017.PubMed/NCBI
|
|
15
|
Wang L, Shen X, Wang Z, Xiao X, Wei P,
Wang Q, Ren F, Wang Y, Liu Z, Sheng W, et al: A molecular signature
for the prediction of recurrence in colorectal cancer. Mol Cancer.
14:222015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yarden Y and Pines G: The ERBB network: At
last, cancer therapy meets systems biology. Nat Rev Cancer.
12:553–563. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hynes NE and Lane HA: ERBB receptors and
cance: The complexity of targeted inhibitors. Nat Rev Cancer.
5:341–354. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang H, Xi Q and Wu G: Fatty acid synthase
regulates invasion and metastasis of colorectal cancer via Wnt
signaling pathway. Cancer Med. 5:1599–1606. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li N, Bu X, Tian X, Wu P, Yang L and Huang
P: Fatty acid synthase regulates proliferation and migration of
colorectal cancer cells Via HER2-PI3K/Akt signaling pathway. Nutr
Cancer. 64:864–870. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nikolayeva O and Robinson MD: edgeR for
Differential RNA-seq and ChIP-seq Analysis: An application to stem
cell biology. Methods Mol Biol. 1150:45–79. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gazzoni GF, Fraga MB, Ferrari ADL, Soliz
PDC, Borges AP, Bartholomay E, Kalil CAA, Giaretta V and Rohde LEP:
Predictors of total mortality and echocardiographic response for
cardiac resynchronization therapy: A cohort study. Arq Bras
Cardiol. 109:569–578. 2017.(In English, Portuguese). PubMed/NCBI
|
|
23
|
Kang JS, Lee S, Son D, Han Y, Lee KB, Kim
JR, Kwon W, Kim SW and Jang JY: Prognostic predictability of the
new American Joint Committee on Cancer 8th staging system for
distal bile duct cancer: Limited usefulness compared with the 7th
staging system. J Hepatobiliary Pancreat Sci. 25:124–130. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu L, Shi M, Wang Z, Lu H, Li C, Tao Y,
Chen X and Zhao J: A molecular and staging model predicts survival
in patients with resected non-small cell lung cancer. BMC Cancer.
18:9662018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ohtsuki I and Morimoto S: Troponin:
Regulatory function and disorders. Biochem Biophys Res Commun.
369:62–73. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wei B and Jin JP: TNNT1, TNNT2, and
TNNT3: Isoform genes, regulation, and structure-function
relationships. Gene. 582:1–13. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Van Spaendonck-Zwarts KY, Van Rijsingen
IA, Van den Berg MP, Lekanne Deprez RH, Post JG, van Mil AM,
Asselbergs FW, Christiaans I, van Langen IM, Wilde AA, et al:
Genetic analysis in 418 index patients with idiopathic dilated
cardiomyopathy: Overview of 10 years' experience. Eur J Heart Fail.
15:628–636. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kong SW, Hu YW, Ho JW, Ikeda S, Polster S,
John R, Hall JL, Bisping E, Pieske B, dos Remedios CG and Pu WT:
Heart failure-associated changes in RNA splicing of sarcomere
genes. Circ Cardiovasc Genet. 3:138–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kozlovski I, Siegfried Z, Amar-Schwartz A
and Karni R: The role of RNA alternative splicing in regulating
cancer metabolism. Human Genet. 136:1113–1127. 2017. View Article : Google Scholar
|
|
30
|
Munkley J, Livermore K, Rajan P and
Elliott DJ: RNA splicing and splicing regulator changes in prostate
cancer pathology. Hum Genet. 136:1143–1154. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lokody I: Alternative splicing: Aberrant
splicing promotes colon tumour growth. Nat Rev Cancer. 14:382–383.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zong Z, Li H, Yi C, Ying H, Zhu Z and Wang
H: Genome-wide profiling of prognostic alternative splicing
signature in colorectal cancer. Front Oncol. 8:5372018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Adams JE III, Bodor GS, Dávila-Román VG,
Delmez JA, Apple FS, Ladenson JH and Jaffe AS: Cardiac troponin I.
A marker with high specificity for cardiac injury. Circulation.
88:101–106. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
De Luca A, Carotenuto A, Rachiglio A,
Gallo M, Maiello MR, Aldinucci D, Pinto A and Normanno N: The role
of the EGFR signaling in tumor microenvironment. J Cell Physiol.
214:559–567. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mallini P, Lennard T, Kirby J and Meeson
A: Epithelial-to-mesenchymal transition: What is the impact on
breast cancer stem cells and drug resistance. Cancer Treat Rev.
40:341–348. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Spano JP, Fagard R, Soria JC, Rixe O,
Khayat D and Milano G: Epidermal growth factor receptor signaling
in colorectal cancer: Preclinical data and therapeutic
perspectives. Ann Oncol. 16:189–194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hung CY, Yeh TS, Tsai CK, Wu RC, Lai YC,
Chiang MH, Lu KY, Lin CN, Cheng ML and Lin G: Glycerophospholipids
pathways and chromosomal instability in gastric cancer: Global
lipidomics analysis. World J Gastrointest Oncol. 11:181–194. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mika A, Kobiela J, Czumaj A, Chmielewski
M, Stepnowski P and Sledzinski T: Hyper-elongation in colorectal
cancer tissue-cerotic acid is a potential novel serum metabolic
marker of colorectal malignancies. Cell Physiol Biochem.
41:722–730. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mirnezami R, Spagou K, Vorkas PA, Lewis
MR, Kinross J, Want E, Shion H, Goldin RD, Darzi A, Takats Z, et
al: Chemical mapping of the colorectal cancer microenvironment via
MALDI imaging mass spectrometry (MALDI-MSI) reveals novel
cancer-associated field effects. Mol Oncol. 8:39–49. 2014.
View Article : Google Scholar : PubMed/NCBI
|
